Embryonic Mouse Hypothalamus Cell Line

Embryonic Mouse Hypothalamus Cell Line is based on a proprietary platform technology which has enabled the creation of a series of Immortalised hypothalamic neurons; Immortalised from mouse embryonic day 15, 17, 18 hypothalamic primary cultures by retroviral transfer of SV40 T-Ag. These cell lines have been found to express an ever expanding array of neuropeptides, enzymatic markers and biologically active receptors. As such, these cell lines enable accurate in-vitro assays for use in the discovery, development and validation of new therapeutics targeted to central-nervous system diseases and disorders, including obesity, stress, and metabolic disorders, amongst others.